# Visiopharm · Pathology image analysis software: AI\-based image analysis software for research and diagnostic \(EU\)

> We provide you with the accuracy and versatility you need to meet the tissue analysis challenges of tomorrow in research and diagnostics\. Whether you’re developing next\-generation therapies or matching these therapies with the right patients, we ensure the quality you need to stay ahead\.

Generated by Yoast SEO v28.0, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Academy](https://visiopharm.com/training/)
- [Customer Program](https://visiopharm.com/customer-program/)
- [Home](https://visiopharm.com/)
- [Diagnostic tissue analysis](https://visiopharm.com/diagnostics-pathology-image-analysis-software/)
- [Privacy policy](https://visiopharm.com/privacypolicy/)

## Posts
- [Flexible analysis for veterinary pathology: Interview with Simone de Brot](https://visiopharm.com/blog/customer-stories/flexible-analysis-for-veterinary-pathology-interview-with-simone-de-brot/)
- [Visiopharm Tech Talks Session 1](https://visiopharm.com/product-releases/visiopharm-tech-talks-session-1/)
- [Grundium acquires Visiopharm to create integrated precision pathology platform](https://visiopharm.com/press-releases/grundium-acquires-visiopharm-to-create-integrated-precision-pathology-platform/)
- [Visiopharm software updates: 2025\.08\.1](https://visiopharm.com/product-releases/visiopharm-software-updates-2025-08-1/)
- [Visiopharm software updates: 2026\.02\.1](https://visiopharm.com/product-releases/software-whatsnew/)

## APP Posts
- [PD\-L1 APP, NSCLC ](https://visiopharm.com/app-center/app/ivdr-pdl1-app-nsclc/)
- [H\&E, Tumor Detection](https://visiopharm.com/app-center/app/he-tumor-detection/)
- [Tissue Detection, Fluorescence, 8bit](https://visiopharm.com/app-center/app/tissue-detection-if-8/)
- [Nuclei DAB Quantification](https://visiopharm.com/app-center/app/nuclei-dab-quantification/)
- [Nuclei DAB Intensity Quantification](https://visiopharm.com/app-center/app/nuclei-dab-intensity-quantification/)

## Resources
- [Masterclass Webinar Series: \</br\> Precision medicine demands precision pathology\. IHC from a Stain to an Assay – The TIME is NOW\.](https://visiopharm.com/resources/masterclass-webinar-series-the-challenges-of-ihc-standardization-clive-taylor/)
- [A comprehensive workflow for highplex imaging, tissue segmentation, and multiplex cellular phenotyping for tumor microenvironment analysis](https://visiopharm.com/resources/a-comprehensive-workflow-for-highplex-imaging-tissue-segmentation-and-multiplex-cellular-phenotyping-for-tumor-microenvironment-analysis/)
- [How using multiplex technology has the potential to inform treatment strategies for precision medicine](https://visiopharm.com/resources/phenoplex-analysis-of-a-30-plex-assay-multiplex-image/)
- [Digital algorithms to predict risk of lymph node metastases in colorectal cancer \| ECDP Poster](https://visiopharm.com/resources/algorithms-to-predict-risk-of-lymph-node-metastases-in-colorectal-cancer/)
- [Spatial analysis of the immunosuppressive tumor microenvironment with SignalStar® multiplex immunohistochemistry](https://visiopharm.com/resources/spatial-analysis-of-the-immunosuppressive-tumor-microenvironment-with-signalstar-multiplex-immunohistochemistry/)

## Optional
- [Sitemap index](https://visiopharm.com/sitemap_index.xml)